🔎 Trials Near Me

Nyumbani › Multiple Myeloma › Maryland › Baltimore

Majaribio ya kliniki ya Multiple Myeloma katika Baltimore, MD

Masomo 13 ya Multiple Myeloma yanatafuta washiriki katika vituo vya Baltimore na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

InaajiriHatua 3
  • Johns Hopkins Hospital, Baltimore
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07518186

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

InaajiriHatua 3
  • University of Maryland School of Medicine, Baltimore
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07258511

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

InaajiriHatua 3
  • Johns Hopkins University School of Medicine JHUSOM, Baltimore
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT05552222

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

InaajiriHatua ya kwanza ya awali
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06398457

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

InaajiriHatua 3
  • Johns Hopkins Asthma & Allergy Center, Baltimore
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT07648264

Collection of Tissue Samples for Cancer Research

InaajiriUtafiti wa uchunguzi
  • Johns Hopkins University, Baltimore
2 Months · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT00900198

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

InaajiriHatua 3
  • University of Maryland | Greenebaum Cancer Center, Baltimore
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT06980480

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

InaajiriHatua 3
  • Research Site, Baltimore
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Ago 2026 · NCT07764978

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

InaajiriHatua 1
  • University of Maryland Greenbaum Comprehensive Cancer Center, Baltimore
Umri 18 na zaidi · Jinsia zote · Imesasishwa 12 Ago 2026 · NCT07280013

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

InaajiriHatua 3
  • Greater Baltimore Medical Center, Baltimore
Umri wote · Jinsia zote · Imesasishwa 10 Jun 2026 · NCT05561387

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

InaajiriHatua 1/2
  • Sibley Memorial Hospital, Baltimore
  • University of Maryland, Baltimore
  • Johns Hopkins Main Center, Baltimore
Umri 12 na zaidi · Jinsia zote · Imesasishwa 24 Mac 2026 · NCT04988555

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

InaajiriHatua 1/2
  • Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Sep 2025 · NCT05372354

Majaribio ya Multiple Myeloma katika miji mingine

Masomo mengine katika Baltimore

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.